163 related articles for article (PubMed ID: 37669906)
1. N
Dong G; Liang Y; Chen B; Zhang T; Wang H; Chen Y; Zhang Y; Jiang F; Wang Y
Thorac Cancer; 2023 Oct; 14(29):2962-2975. PubMed ID: 37669906
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miR-628-5p from M1 polarized macrophages hinders m6A modification of circFUT8 to suppress hepatocellular carcinoma progression.
Wang L; Yi X; Xiao X; Zheng Q; Ma L; Li B
Cell Mol Biol Lett; 2022 Dec; 27(1):106. PubMed ID: 36474147
[TBL] [Abstract][Full Text] [Related]
3. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of N
Li J; Meng S; Xu M; Wang S; He L; Xu X; Wang X; Xie L
Oncotarget; 2018 Jan; 9(3):3752-3764. PubMed ID: 29423080
[TBL] [Abstract][Full Text] [Related]
5. YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.
Bai X; Chen J; Zhang W; Zhou S; Dong L; Huang J; He X
Cancer Sci; 2023 Nov; 114(11):4299-4313. PubMed ID: 37700438
[TBL] [Abstract][Full Text] [Related]
6. PA2G4 promotes the metastasis of hepatocellular carcinoma by stabilizing FYN mRNA in a YTHDF2-dependent manner.
Sun S; Liu Y; Zhou M; Wen J; Xue L; Han S; Liang J; Wang Y; Wei Y; Yu J; Long X; Chen X; Liang H; Huang Z; Zhang B
Cell Biosci; 2022 May; 12(1):55. PubMed ID: 35526051
[TBL] [Abstract][Full Text] [Related]
7. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
[TBL] [Abstract][Full Text] [Related]
8. Function and prognostic value of N6-methyladenosine-modified RNAs in lung adenocarcinoma.
Liu J; Zheng Z; Zhong J
J Gene Med; 2023 Jan; 25(1):e3454. PubMed ID: 36282144
[TBL] [Abstract][Full Text] [Related]
9. circRNA circFUT8 Upregulates Krüpple-like Factor 10 to Inhibit the Metastasis of Bladder Cancer via Sponging miR-570-3p.
He Q; Yan D; Dong W; Bi J; Huang L; Yang M; Huang J; Qin H; Lin T
Mol Ther Oncolytics; 2020 Mar; 16():172-187. PubMed ID: 32072011
[TBL] [Abstract][Full Text] [Related]
10. RNA m
Li Y; Sheng H; Ma F; Wu Q; Huang J; Chen Q; Sheng L; Zhu X; Zhu X; Xu M
Cell Death Dis; 2021 May; 12(5):479. PubMed ID: 33980824
[TBL] [Abstract][Full Text] [Related]
11. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
[TBL] [Abstract][Full Text] [Related]
12. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
13. Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression.
Du C; Lv C; Feng Y; Yu S
J Exp Clin Cancer Res; 2020 Oct; 39(1):223. PubMed ID: 33087165
[TBL] [Abstract][Full Text] [Related]
14. HNRNPA2B1 inhibited SFRP2 and activated Wnt-β/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.
Rong L; Xu Y; Zhang K; Jin L; Liu X
Pathol Res Pract; 2022 May; 233():153794. PubMed ID: 35364458
[TBL] [Abstract][Full Text] [Related]
15. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
Yang Z; Cai Z; Yang C; Luo Z; Bao X
EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
[TBL] [Abstract][Full Text] [Related]
16. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.
Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q
J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396
[TBL] [Abstract][Full Text] [Related]
17. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m
Xu Y; Lv D; Yan C; Su H; Zhang X; Shi Y; Ying K
Cancer Cell Int; 2022 Jan; 22(1):11. PubMed ID: 34996469
[TBL] [Abstract][Full Text] [Related]
18. Potential impact of WTAP and YTHDF2 on tumor immunity in lung adenocarcinoma.
Zhang X; Cai X
Medicine (Baltimore); 2022 Nov; 101(45):e31195. PubMed ID: 36397411
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of microRNA-6125 promotes colorectal cancer growth through YTHDF2-dependent recognition of N6-methyladenosine-modified GSK3β.
Li H; Zhang N; Jiao X; Wang C; Sun W; He Y; Ren G; Huang S; Li M; Chang Y; Jin Z; Xie Q; Zhang X; Huang H; Jin H
Clin Transl Med; 2021 Oct; 11(10):e602. PubMed ID: 34709763
[TBL] [Abstract][Full Text] [Related]
20. SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.
Hou G; Zhao X; Li L; Yang Q; Liu X; Huang C; Lu R; Chen R; Wang Y; Jiang B; Yu J
Nucleic Acids Res; 2021 Mar; 49(5):2859-2877. PubMed ID: 33577677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
